Sort By:

International Winter Conference on Alzheimer's Disease 2012

Zuers—Meeting Mixes Translational News and Debate Zuers—Αlpha, Beta, Sigma: Which Will Yield New AD Drug? Zuers—No Pill or Drip: Scientists Inject Phage Drug Into CSF Zuers—Can Spatial Navigation Guide Clinical Trials? The town of Zuers in the Austrian ...

ApoE, ApoE Receptors & Neurodegeneration

St. Louis: ApoE Receptors—Hold Sway Over Synaptic Function St. Louis: ApoE—Receptors, Theories and Therapies St. Louis: ApoE—A Clearer View of its Role In AD? The apolipoprotein E gene is the strongest genetic risk factor for late-onset Alzheimer disease. ...

Keystone: Slalom No Match for Ins and Outs of ApoE Research

Keystone: Symposium Emphasizes Key Aspects of ApoE Biology Keystone: Probing the Function of Lipoprotein and Related Receptors Keystone: ApoE Receptors and Ligands in Memory and AD Keystone: Does ApoE Fragmentation Drive Pathology? Keystone: Therapies ...

Keystone Symposium: Adult Neurogenesis

Taos: New Neurons in New Mexico—Highlights from Keystone Taos: Disease, Drug Development, and Adult Neurogenesis It turns out you are not born with all the neurons you’ll ever need; adult neurogenesis is alive and kicking in the mammalian brain. Most ...

Keystone: Researchers Report on Traumatic Encephalopathy Meeting

Keystone: Traumatic Brain Injury—Epidemiology and Characteristics Keystone: Sports-Related Injury and Chronic Traumatic Encephalopathy Keystone: Metabolic and Axonal Dysfunction in Traumatic Brain Injury Keystone: TBI—Learning From Markers, Models, and ...

Gladstone Workshop: ApoE4

San Francisco: Tweaking Brain ApoE Reduces Aβ, Symptoms San Francisco: GABA Neurons Blamed for Memory Loss in ApoE Mice Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant ...

Northeast ALS Consortium 2011

NEALS: Collaboration for a Cure to ALS NEALS: In ALS Trials, One Design Does Not Fit All NEALS: Desperately Seeking ALS Biomarkers NEALS: Sharing Among ALS Researchers and Participants Starting on October 26, 2011, clinicians and some people with ...

Alzheimer’s Prevention Initiative Workshop: Colombian Families

Colombians Come to Fore in Alzheimer’s Research, Mass Media A Neurologist’s Devotion Puts Familial AD Research Onto New Plane Detecting Familial AD Ever Earlier: Subtle Memory Signs 15 Years Before Scientists and Regulators Discuss Preclinical AD Trials ...

Frontotemporal Dementia Treatment: 2011 Study Group Meeting

Las Vegas: Lou Ruvo Center Pioneers New Approach to Clinical Trials Las Vegas: Are Frontotemporal Dementia Models Fit for Pharma? Las Vegas: Can Collaboration Speed Drug Discovery for FTD? The Lou Ruvo Center for Brain Health opened in Las Vegas in 2009 ...

Gladstone Workshop: Tau and Tauopathies: Pathogenic Mechanisms

San Francisco: Gladstone Institute Hosts Tau Powwow San Francisco: Making Tau Toxic—Post-translational Changes Galore San Francisco: Is Tau Reduction a Good Thing? San Francisco: Tau—Time to Shine as Therapeutic Target? Tauists are having their heyday. ...

Toward a New Research Agenda in Alzheimer’s Disease

From Australia, Impulse for a New Alzheimer’s Research Agenda Australia Report: Genetics and Aging Australia Report: Protein Aggregation, Selective Vulnerability, Spreading Australia Report: Aβ Toxicity, ApoE Australia Report: Inflammation Australia ...

Zilkha Symposium on Alzheimer’s Disease and Related Disorders

It’s Not All About You, Neurons. Glia, Blood, Arteries Shine at Symposium Fluid Markers and Imaging Back Idea of Breached Blood-Brain Barrier In Revival of Parabiosis, Young Blood Rejuvenates Aging Microglia, Cognition Glymphatic Flow, Sleep, microRNA Are ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From